{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:59:47Z","timestamp":1789919987398,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Guilin Scientific Research and Technology Development Project","award":["20140120-1-8"],"award-info":[{"award-number":["20140120-1-8"]}]},{"name":"Guangxi Medical and Health Appropriate Technology Research and Development Project","award":["S201407-03"],"award-info":[{"award-number":["S201407-03"]}]},{"name":"Guangxi Special Topics on Inheritance and Innovation of Traditional Chinese Medicine","award":["GZLC16-45"],"award-info":[{"award-number":["GZLC16-45"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jns.2016.08.061","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T10:37:19Z","timestamp":1473158239000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Role of Rho-mediated ROCK-Semaphorin3A signaling pathway in the pathogenesis of Parkinson's disease in a mouse model"],"prefix":"10.1016","volume":"370","author":[{"given":"Li","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.jns.2016.08.061_bb0005","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1556\/650.2015.30191","article-title":"Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches","volume":"156","author":"Faludi","year":"2015","journal-title":"Orv. Hetil."},{"issue":"10","key":"10.1016\/j.jns.2016.08.061_bb0010","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","article-title":"Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study","volume":"14","author":"Nalls","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2016.08.061_bb0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mds.25019","article-title":"The significance of defining preclinical or prodromal Parkinson's disease","volume":"27","author":"Olanow","year":"2012","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2016.08.061_bb0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3 Suppl. 1","key":"10.1016\/j.jns.2016.08.061_bb0025","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","article-title":"Biomarkers of Parkinson's disease: present and future","volume":"64","author":"Miller","year":"2015","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.jns.2016.08.061_bb0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson's disease (recent update)","volume":"63","author":"Sharma","year":"2013","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.jns.2016.08.061_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson's disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.08.061_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnins.2015.00198","article-title":"Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders","volume":"9","author":"Hensel","year":"2015","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2016.08.061_bb0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5966\/sctm.2015-0182","article-title":"Effects of Rho kinase inhibitors on grafts of dopaminergic cell precursors in a rat model of Parkinson's disease","volume":"5","author":"Rodriguez-Pallares","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jns.2016.08.061_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.niox.2014.09.002","article-title":"Rho-kinase as a therapeutic target in vascular diseases: striking nitric oxide signaling","volume":"43","author":"Kolluru","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jns.2016.08.061_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2013.06.004","article-title":"Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease","volume":"58","author":"Rodriguez-Perez","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2016.08.061_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2011.00039","article-title":"ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration","volume":"4","author":"Tonges","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2016.08.061_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.cellbio.22.010605.093554","article-title":"Semaphorin regulation of cellular morphology","volume":"23","author":"Tran","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.jns.2016.08.061_bb0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00467-013-2743-x","article-title":"Semaphorin3A signaling, podocyte shape, and glomerular disease","volume":"29","author":"Tufro","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2016.08.061_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2005.02.064","article-title":"Toxicity of semaphorin3A for dopaminergic neurons","volume":"382","author":"Yasuhara","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jns.2016.08.061_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(00)80063-X","article-title":"Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates","volume":"99","author":"Tamagnone","year":"1999","journal-title":"Cell"},{"issue":"9680","key":"10.1016\/j.jns.2016.08.061_bb0085","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2016.08.061_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1734-1140(13)70962-9","article-title":"Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease","volume":"65","author":"Schwenkgrub","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.jns.2016.08.061_bb0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2010.12.009","article-title":"Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL\/6 mice","volume":"69","author":"Muroyama","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jns.2016.08.061_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","article-title":"Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death","volume":"85","author":"Borrajo","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jns.2016.08.061_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"Mueller","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jns.2016.08.061_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1471-4159.2007.04756.x","article-title":"Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo","volume":"103","author":"Lingor","year":"2007","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.jns.2016.08.061_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2015.03.022","article-title":"Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease","volume":"353","author":"Zhao","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2016.08.061_bb0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ni.1885","article-title":"Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II","volume":"11","author":"Takamatsu","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2016.08.061_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/jhg.2014.107","article-title":"PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure","volume":"60","author":"Belyk","year":"2015","journal-title":"J. Hum. Genet."},{"issue":"25","key":"10.1016\/j.jns.2016.08.061_bb0130","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.lfs.2006.08.005","article-title":"Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1","volume":"79","author":"Starzec","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jns.2016.08.061_bb0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1742-2094-9-218","article-title":"Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability","volume":"9","author":"Suidan","year":"2012","journal-title":"J. Neuroinflammation"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16305524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16305524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:39:53Z","timestamp":1718779193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16305524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":27,"alternative-id":["S0022510X16305524"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.08.061","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Rho-mediated ROCK-Semaphorin3A signaling pathway in the pathogenesis of Parkinson's disease in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}